Breaking News Instant updates and real-time market news.

CELG

Celgene

$86.95

-1.89 (-2.13%)

, AGIO

Agios Pharmaceuticals

$73.22

-1.23 (-1.65%)

06:27
04/09/18
04/09
06:27
04/09/18
06:27

Celgene M&A targets may include Agios, Jounce, FT reports

Celgene (CELG) is on the hunt for acquisition targets, according to sources cited by the Financial Times. According to a source, Celgene is "absolutely" working on acquisitions to bolster the pipeline as investors press management to conduct further M&A following the recent $9B takeover of cancer cell therapy company Juno. Potential targets include Agios (AGIO) and Jounce (JNCE), according to the sources. Reference Link

CELG

Celgene

$86.95

-1.89 (-2.13%)

AGIO

Agios Pharmaceuticals

$73.22

-1.23 (-1.65%)

JNCE

Jounce Therapeutics

$18.48

-1.23 (-6.24%)

  • 09

    Apr

  • 08

    May

  • 18

    May

  • 30

    May

  • 21

    Aug

CELG Celgene
$86.95

-1.89 (-2.13%)

04/03/18
JMPS
04/03/18
NO CHANGE
JMPS
Market Perform
Celgene COO departure not a surprise, says JMP Securities
JMP Securities analyst Michael King said he was not surprised by the announcement that Celgene COO Scott Smith is exiting given the recent missteps in the company's Inflammation and Immunology franchise. This appears to be the first major step in restructuring Celgene's executive team and he hopes the evolving management structure improves execution and accountability, King tells investors. Although valuation seems to be at extreme lows, King thinks Celgene shares will have a hard time recovering until the company can demonstrate it has regained its ability to drive value, either through execution or an acquisition. He keeps a Market Perform rating on the stock.
03/28/18
LEER
03/28/18
NO CHANGE
Target $123
LEER
Outperform
Leerink sees 60% upside in Celgene shares under 'base case' scenario
Leerink analyst Geoffrey Porges says his sum-of-the-parts analysis suggests Celgene shares are discounting zero cash flow from Revlimid after 2022 and no approval ever of ozanimod or luspatercept. His "base case" scenario, which includes a slow revenue decline for Revlimid post 2022 and ozanimod's approval in multiple sclerosis during 2019 with a 50% probability of success in all indications, results in a net present value of $140 per share, which is 60% above the current share stock price. Celgene closed yesterday down $1.36 to $85.81. Porges' "worst case" scenario, which assumes no Revlimid contribution post 2022 and neither ozanimod nor luspatercept, has the stock worth $87. Celgene shares discounting "such a bad outlook" is no surprise after the company's "recent missteps and misjudgments," but the stock offers "remarkable upside" to investors willing to step in at the current "distressed" valuation," Porges tells investors in a research note. He keeps an Outperform rating on Celgene with a $123 price target.
03/28/18
03/28/18
NO CHANGE

Bluebird Bio and Celegene to co-develop bb2121 anti-BMCA therapy
Bluebird Bio (BLUE) and Celgene (CELG) announced that the companies have entered into an agreement to co-develop and co-promote bb2121, an investigational anti-B-cell maturation antigen, or BCMA chimeric antigen receptor, or CAR, T cell therapy for the potential treatment of patients with relapsed/refractory multiple myeloma in the United States.The companies originally entered into a broad, global strategic research collaboration in 2013 to discover, develop and commercialize novel therapies in oncology, which included bb2121.
03/27/18
EVER
03/27/18
NO CHANGE
Target $155
EVER
Outperform
Evercore sees higher chances of Revlimid patent settlement for Celgene
Evercore ISI analyst Umer Raffat believes the odds of a Revlimid patent settlement between Celgene (CELG) and Dr. Reddy's (RDY) have gone up "considerably" following a recent court filing. The filing, according to the analyst, shows Dr. Reddy's agreed to resolve claims construction issues, which he believes "implies a clear alignment in thought process between both sides." A potential settlement on Revlimid remains the biggest catalyst on Celgene in 2018, and could lead a quick re-rating in the valuation multiple, Raffat tells investors in a research note. He keeps Celgene as his top pick for 2018 with an Outperform rating and $155 price target.
AGIO Agios Pharmaceuticals
$73.22

-1.23 (-1.65%)

02/15/18
RHCO
02/15/18
NO CHANGE
Target $101
RHCO
Buy
Agios Pharmaceuticals price target raised to $101 from $80 at SunTrust
SunTrust analyst Yatin Suneja raised his price target on Agios Pharmaceuticals to $101, citing increasing value of AG-348 that is expected to begin in Q2 of this year. The analyst also points to AG-270 trial starting in Q1 of this year and a perioperative "window" study of ivosidenib/AG-881 in glioma as potential catalysts. Suneja concludes that 4 Agios Pharmaceuticals is "making rapid progress on al fronts", keeping his Buy rating on the stock.
02/15/18
FBCO
02/15/18
NO CHANGE
Target $80
FBCO
Outperform
Agios Pharmaceuticals price target raised to $80 from $66 at Credit Suisse
Credit Suisse analyst Alethia Young raised her price target for Agios Pharmaceuticals to $80 from $66 as she sees upside opportunities in her valuation model related to newly diagnosed success in ivosidenib, PKD, AG-270 and DHODH. The analyst reiterates an Outperform rating on the shares.
02/14/18
OPCO
02/14/18
DOWNGRADE
OPCO
Perform
Oppenheimer downgrades Agios on valuation after Q4 results
Oppenheimer analyst Leah Rush Cann downgraded Agios Pharmaceuticals to Perform from Outperform following this morning's Q4 results. The analyst, who rescinded her price target, says that while the company's pipeline programs are moving forward, the shares trade inline with her valuation following the substantial rally over the previous 12 months. Cann adds Agios's recent capital raise resulted in approximately 17% dilution.
02/14/18
OPCO
02/14/18
DOWNGRADE
OPCO
Perform
Agios Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
JNCE Jounce Therapeutics
$18.48

-1.23 (-6.24%)

TODAY'S FREE FLY STORIES

CNMD

CONMED

$63.14

1.36 (2.20%)

21:15
04/25/18
04/25
21:15
04/25/18
21:15
Recommendations
CONMED analyst commentary at Piper Jaffray »

CONMED price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 23

    May

SSNLF

Samsung

20:48
04/25/18
04/25
20:48
04/25/18
20:48
Hot Stocks
Samsung sees Q2 DRAM demand to stay solid and NAND demand to strengthen »

Sees Q2 demand for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

AXS

Axis Capital

$56.82

-0.255 (-0.45%)

20:34
04/25/18
04/25
20:34
04/25/18
20:34
Earnings
Axis Capital reports Q1 adjusted EPS $1.46, consensus $1.16 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

VERI

Veritone

$16.92

-0.18 (-1.05%)

20:31
04/25/18
04/25
20:31
04/25/18
20:31
Hot Stocks
Veritone to integrate BrainChip Holding AI machine learning applications »

BrainChip Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 29

    May

ENB

Enbridge

$29.27

-0.13 (-0.44%)

, EEP

Enbridge Energy

$10.55

0.29 (2.83%)

20:28
04/25/18
04/25
20:28
04/25/18
20:28
Hot Stocks
Enbridge completes assessment of judge recommendations on Line 3 replacement »

After review of the…

ENB

Enbridge

$29.27

-0.13 (-0.44%)

EEP

Enbridge Energy

$10.55

0.29 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 10

    May

  • 10

    May

PEP

PepsiCo

$101.11

-0.32 (-0.32%)

, ABBV

AbbVie

$91.91

0.57 (0.62%)

20:25
04/25/18
04/25
20:25
04/25/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PEP

PepsiCo

$101.11

-0.32 (-0.32%)

ABBV

AbbVie

$91.91

0.57 (0.62%)

UNP

Union Pacific

$136.11

3.3 (2.48%)

UPS

UPS

$108.54

0.34 (0.31%)

BMY

Bristol-Myers

$51.78

0.2 (0.39%)

COP

ConocoPhillips

$65.07

-0.24 (-0.37%)

TWX

Time Warner

$96.27

0.25 (0.26%)

RTN

Raytheon

$213.25

-5.5 (-2.51%)

CME

CME Group

$161.07

-0.52 (-0.32%)

GM

General Motors

$38.10

0.18 (0.47%)

ITW

Illinois Tool Works

$151.68

2.1 (1.40%)

SPGI

S&P Global

$189.68

0.62 (0.33%)

VLO

Valero

$108.68

0.37 (0.34%)

PX

Praxair

$149.84

3.05 (2.08%)

LUV

Southwest

$53.85

-0.03 (-0.06%)

HLT

Hilton

$81.85

-0.19 (-0.23%)

RCL

Royal Caribbean

$118.49

1.2 (1.02%)

ALXN

Alexion

$106.07

-0.37 (-0.35%)

IP

International Paper

$53.44

0.68 (1.29%)

MGM

MGM Resorts

$35.32

-0.2 (-0.56%)

HSY

Hershey

$93.51

0.7 (0.75%)

DHI

D.R. Horton

$44.94

1.195 (2.73%)

NLSN

Nielsen

$34.34

0.835 (2.49%)

DPZ

Domino's Pizza

$233.00

0.925 (0.40%)

TSCO

Tractor Supply

$62.21

1 (1.63%)

DNKN

Dunkin' Brands

$62.13

0.92 (1.50%)

CRI

Carter's

$104.96

0.95 (0.91%)

TREE

LendingTree

$307.20

-20.45 (-6.24%)

SAVE

Spirit Airlines

$37.64

-0.615 (-1.61%)

KBR

KBR

$16.02

-0.255 (-1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 02

    May

  • 02

    May

  • 07

    May

  • 08

    May

  • 10

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 24

    May

  • 24

    May

  • 30

    May

  • 05

    Jun

  • 12

    Jun

  • 14

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

  • 10

    Jul

ROK

Rockwell Automation

$167.30

5.335 (3.29%)

20:08
04/25/18
04/25
20:08
04/25/18
20:08
Downgrade
Rockwell Automation rating change at Vertical Research »

Rockwell Automation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SNDE

Sundance Energy

$4.53

-0.03 (-0.66%)

, PXD

Pioneer Natural

$198.97

2.96 (1.51%)

20:02
04/25/18
04/25
20:02
04/25/18
20:02
Hot Stocks
Sundance Energy Australia acquires Eagle Ford assets, announces equity raise »

Sundance Energy Australia…

SNDE

Sundance Energy

$4.53

-0.03 (-0.66%)

PXD

Pioneer Natural

$198.97

2.96 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 07

    May

  • 22

    May

SSNLF

Samsung

19:51
04/25/18
04/25
19:51
04/25/18
19:51
Earnings
Samsung reports Q1 net profit KRW 11.61T »

Compares to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

CHKP

Check Point

$96.33

-6.62 (-6.43%)

19:42
04/25/18
04/25
19:42
04/25/18
19:42
Recommendations
Check Point analyst commentary at Jefferies »

Check Point price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

QTS

QTS Realty Trust

$34.04

0.31 (0.92%)

19:35
04/25/18
04/25
19:35
04/25/18
19:35
Recommendations
QTS Realty Trust analyst commentary at MUFG »

QTS Realty Trust price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

STB

Student Transportation

19:23
04/25/18
04/25
19:23
04/25/18
19:23
Hot Stocks
Student Transportation obtains court order approving Spinner Can Acquireco deal »

Student Transportation is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCMGY

Newcrest Mining

19:15
04/25/18
04/25
19:15
04/25/18
19:15
Hot Stocks
Newcrest Mining reports Q3 gold production 576K oz, down 6% from last quarter »

Reports Q3 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSA

Public Storage

$193.62

-0.115 (-0.06%)

19:04
04/25/18
04/25
19:04
04/25/18
19:04
Hot Stocks
Public Storage names Natalia Johnson chief HR officer »

Ronald L. Havner, Jr.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

CADE

Cadence Bancorp

$28.80

-0.14 (-0.48%)

19:03
04/25/18
04/25
19:03
04/25/18
19:03
Earnings
Cadence Bancorp reports Q1 EPS 46c, consensus 44c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 14

    May

  • 24

    Sep

USAK

USA Truck

$25.56

-0.84 (-3.18%)

19:02
04/25/18
04/25
19:02
04/25/18
19:02
Hot Stocks
USA Truck names Tim Guin as EVP and Chief Commercial Officer »

USA Truck announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

BCS

Barclays

$12.01

-0.085 (-0.70%)

, PYPL

PayPal

$74.00

-1.29 (-1.71%)

19:01
04/25/18
04/25
19:01
04/25/18
19:01
Hot Stocks
Barclays, PayPal announces strategic partnership »

Barclays (BCS) announced…

BCS

Barclays

$12.01

-0.085 (-0.70%)

PYPL

PayPal

$74.00

-1.29 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 22

    May

  • 23

    May

  • 12

    Jun

ORLY

O'Reilly Automotive

$228.03

3.31 (1.47%)

, CMG

Chipotle

$339.30

6.4 (1.92%)

19:00
04/25/18
04/25
19:00
04/25/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

ORLY

O'Reilly Automotive

$228.03

3.31 (1.47%)

CMG

Chipotle

$339.30

6.4 (1.92%)

PCMI

PCM, Inc.

$10.60

0.1 (0.95%)

AMD

AMD

$9.72

-0.37 (-3.67%)

FB

Facebook

$159.69

0.03 (0.02%)

ECHO

Echo Global

$27.80

0.15 (0.54%)

XLNX

Xilinx

$63.70

-0.34 (-0.53%)

PYPL

PayPal

$74.00

-1.29 (-1.71%)

ALGN

Align Technology

$245.24

5.72 (2.39%)

CTXS

Citrix

$96.54

0.04 (0.04%)

V

Visa

$121.00

-0.41 (-0.34%)

CLGX

CoreLogic

$43.85

-0.57 (-1.28%)

F

Ford

$11.11

0.16 (1.46%)

QCOM

Qualcomm

$49.77

-0.17 (-0.34%)

LVS

Las Vegas Sands

$72.42

-1.38 (-1.87%)

LM

Legg Mason

$37.64

0.25 (0.67%)

INTU

Intuit

$176.38

-2.25 (-1.26%)

TWTR

Twitter

$29.88

-0.6 (-1.97%)

FARO

FARO Technologies

$60.50

-1.85 (-2.97%)

LMAT

LeMaitre

$39.00

0.19 (0.49%)

UHS

Universal Health

$122.03

1.5 (1.24%)

EBAY

eBay

$40.98

-0.2 (-0.49%)

T

AT&T

$35.19

0.19 (0.54%)

KEX

Kirby

$82.95

-1.85 (-2.18%)

GG

Goldcorp

$13.97

-0.38 (-2.65%)

BMRN

BioMarin

$81.41

0.33 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 30

    Apr

  • 01

    May

  • 01

    May

  • 02

    May

  • 02

    May

  • 08

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 10

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 12

    Jun

  • 27

    Jul

  • 12

    Sep

NBIX

Neurocrine

$78.13

-0.3 (-0.38%)

18:59
04/25/18
04/25
18:59
04/25/18
18:59
Hot Stocks
Neurocrine says Ingrezza improved TD symptoms regardless of body region »

Neurocrine Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

AZPN

Aspen Technology

$85.50

0.39 (0.46%)

18:54
04/25/18
04/25
18:54
04/25/18
18:54
Earnings
Aspen Technology raises FY18 adj. EPS view to $2.24-$2.27 from $2.16-$2.21 »

Consensus $2.21. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 12

    Jun

AZPN

Aspen Technology

$85.50

0.39 (0.46%)

18:53
04/25/18
04/25
18:53
04/25/18
18:53
Earnings
Aspen Technology sees Q4 adjusted EPS 53c-55c, consensus 57c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 12

    Jun

ESV

Ensco

$6.03

-0.15 (-2.43%)

18:52
04/25/18
04/25
18:52
04/25/18
18:52
Earnings
Ensco reports Q1 adjusted EPS (32c), consensus (27c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CLB

Core Laboratories

$120.25

2.07 (1.75%)

18:50
04/25/18
04/25
18:50
04/25/18
18:50
Earnings
Core Laboratories sees Q2 EPS 64c-66c, consensus 66c »

Expects Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 01

    May

  • 01

    May

  • 07

    May

SPY

SPDR S&P 500 ETF Trust

$263.64

0.52 (0.20%)

, SPX

S&P 500

18:47
04/25/18
04/25
18:47
04/25/18
18:47
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

France's Macron sees…

SPY

SPDR S&P 500 ETF Trust

$263.64

0.52 (0.20%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

18:41
04/25/18
04/25
18:41
04/25/18
18:41
Periodicals
Breaking Periodicals news story on Samsung »

Samsung to sell Hanwha…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.